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Background
Over 25,000 HIV-infected children are currently alive
and on highly active antiretroviral therapy (HAART) in
India. Limited data are available on the efficacy of treat-
ment and emergence of drug resistance (DR) in pedia-
tric populations. In this study we aimed to characterize
the pattern of drug resistance mutations (DRM) in a
cohort of perinatally infected children.
Method
Blood samples were collected from 61 children who were
on first line of therapy for ≥ 6 months. Patients’ demo-
graphic and clinical parameters were documented. Viral
load was measured using Abbott m2000rt system, Ger-
many. DR Genotyping (using an in-house method) was
performed on those with viral load >1000 copies/ml.
Results
Among those who had been on ART for a median period of
24 months 51 children (83.6%) achieved virological suppres-
sion. There were 10 children with virological failure, and
only two amongst these manifested immunological failure.
Nine children (90%) had reverse transcriptase-related
DRMs, and none had protease inhibitor-related DRMs. The
most frequent NRTI mutation was M184V (n=9) followed
by two thymidine analogous associated mutations (TAMs)
M41L and T215Y (n=2). The most frequent nNRTI muta-
tions were K103N (n=6) and Y181C (n=3).
Conclusion
Our study showed a high proportion of children achiev-
ing virological suppression with a mean duration of two
years of ART. Children with virological failure and drug
resistance and without immunological failure will likely
promote DRM accumulation and may jeopardise sec-
ond-line ART options. These data suggest that virologi-
cal monitoring may help optimise regimen switch in
children.
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